EMERGO SUMMARY OF KEY POINTS:
Health Canada to publish new guidance on MDL requirements for 3D-printed medical devices.
The Draft guidance will cover Class III and Class IV 3D-printed devices.
Publication expected in fall 2018.
Emergo is a Texas-based company that provides services such as regulatory compliance, clinical trials and market access for the pharmaceutical and biotechnology industries.